Bing-Yuan Ou

Urinary CD14 as a potential biomarker for benign prostatic hyperplasia – discovery by combining MALDI‐TOF‐based biostatistics and ESI‐MS/MS‐based stable‐isotope labeling

T. Tzai, Shu-Hui Chen, N. Chow, 2011, Proteomics. Clinical applications.